The autism susceptibility candidate 2 (AUTS2, also termed “activator of transcription and developmental regulator” by the HUGO Gene Nomenclature Committee, #14262) gene was initially reported as an ASD risk gene disrupted by de novo balanced chromosomal translocation in monozygotic twins with ASD in 2002 [11]. The gene discussed is AUTS2; the disease is autism.